# Exploring Conduct Disorder and Cannabis Use in Teens > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/conduct-disorder-substance-use-disorders-teens/ > **Published:** 2020-06-09T13:49:41-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:17:31-04:00 > **Clinical Summary:** Explore the link between conduct disorder substance use disorders and cannabis in teens, highlighting risks and demographics for targeted prevention. --- **Conduct disorder-related hospitalization and [substance use disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) in American teens** In Summary [Cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) was found to highly correlate with inpatients diagnosed with conduct disorder amongst teenagers. Although some [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) was self-reported by patients dealing with other psychiatric disorders, it was seen most significantly in those with conduct disorder (CD), suggesting a higher risk of comorbidity between CD and [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) disorders. Although cannabis use was the most common substance reported by patients it was closely followed by tobacco and alcohol use. The demographics of patients using cannabis varied although those suffering from CD and [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) disorder were primarily male and black. Further research should be conducted to develop efficient prevention strategies. Looking into the substance use frequency and patterns of stigmatized or marginalized groups is not often done leaving many populations without specialized treatment or prevention programs. If members of the male black population are at a higher risk of developing [substance use disorders](https://cedclinic.com/cannabinoid-clinical-trials-mental-disorders-evidence-2/) then our prevention efforts should address that population first and foremost. People begin using substances for different reasons although some motivations are common among certain populations. By examining the underlying motivation for substance use frequency members of the healthcare community may be able to develop custom prevention or treatment methods by utilizing psychology or another science to drastically decrease the frequency of substance use disorders in all populations. The study is available for review or download here: [DOWNLOAD & REVIEW HERE](https://www.cedfoundation.com/wp-content/uploads/2020/03/Conduct-Disorder-Related-Hospitalization-and-Substance-Use-Disorders-in-American-Teens.pdf) View more studies like this in the CED Foundation Archive: [http://bit.ly/drcaplan](http://bit.ly/drcaplan) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Association of Cannabis Use Disorder Versus Other Substance Use Disorders … – Psychiatry Online](https://cedclinic.com/psychiatric-outcomes-cannabis-use-disorder-comparison/) Explore the differences and overlaps between [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) and other substance use disorders in psychiatric populations. [Read More](https://cedclinic.com/psychiatric-outcomes-cannabis-use-disorder-comparison/) [Kaiser Study Finds Higher Risk of Psychiatric Disorders in Teens Who Use Cannabis](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) This study highlights the increased psychiatric risks associated with cannabis use among teenagers. [Learn More](https://cedclinic.com/adolescent-cannabis-psychiatric-outcomes-2026-digest/) [Teen cannabis use trends mirror established alcohol consumption patterns](https://cedclinic.com/teen-cannabis-use-trends-alcohol-consumption-patterns/) An analysis of how teen cannabis use trends compare to [alcohol consumption patterns](https://cedclinic.com/cannabis-infused-drinks-may-help-people-cut-their-alcohol-intake-in-half/), providing insight into substance use behaviors. [Explore Trends](https://cedclinic.com/teen-cannabis-use-trends-alcohol-consumption-patterns/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Exploring%20Conduct%20Disorder%20and%20Cannabis%20Use%20in%20Teens&url=https%3A%2F%2Fcedclinic.com%2Fconduct-disorder-substance-use-disorders-teens%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fconduct-disorder-substance-use-disorders-teens%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Exploring%20Conduct%20Disorder%20and%20Cannabis%20Use%20in%20Teens%20https%3A%2F%2Fcedclinic.com%2Fconduct-disorder-substance-use-disorders-teens%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).